US 2003/0190351 A1Published application

Extended release venlafaxine formulations

AssigneeSynthon BV

InventorsJohannes Jan Platteeuw, Inocencia Margallo Lana, Arturo Siles Ortega

Life of this patent

Estimating the term…

Abstract

A pharmaceutical composition is provided comprising venlafaxine hydrochloride and sodium carboxymethyl cellulose. The composition can be formulated to provide controlled release of the venlafaxine hydrochloride.

Claims17

Dependent claims

A pharmaceutical composition comprising venlafaxine hydrochloride and sodium carboxymethyl cellulose.

Dependencies are inferred from the claim text.

Facts

Application: 10/397,350Filed 27 Mar 2003
Priority: 28 Mar 2002
Published: 9 Oct 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 31/135
Amines: having aromatic rings , e.g. ketamine, nortriptyline
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61P 25/24
Drugs for disorders of the nervous system: antidepressants

Family

Application60/367,735Us provisional application · filed 28 Mar 2002
US 2003/0190351 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results